NLS Pharmaceutics Overview
NLS Pharmaceutics Discounted Cash Flow
DCF Analysis for NLSP.
Get informed when a big investor buys or sells
+ FollowFair Value
$1.08
Current Fair Value
$1.08
↓ 62.9% Downside
Overvalued by 62.9% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison